Related by context. Frequent words. (Click for all words.) 59 double blinded placebo 58 phase IIb 58 Phase 1b clinical 56 Phase 2a clinical 56 orally bioavailable 56 Phase 2a trial 56 phase 2a 56 Phase 1b 55 dose escalation trial 55 Phase IIb clinical 55 Phase 1b trial 55 Phase IIa clinical 55 confirmatory Phase III 55 Phase 2b trial 55 Phase Ib 55 Phase 1a 55 Phase 2b study 54 placebo controlled clinical 54 Phase 2b clinical 54 Amrubicin 54 phase IIa 54 KNS # 54 Phase Ia 54 Pivotal Phase III 54 blind randomized 53 Phase 2b 53 Phase III randomized 53 Laquinimod 53 Phase 2a 53 Pivotal Phase 53 Phase III 53 Phase IIb 53 blinded placebo controlled 53 multicenter randomized double 53 pivotal Phase III 52 blind randomized controlled 52 multicenter randomized 52 Phase IIa 52 ATTRACT 52 IND enabling 52 nab paclitaxel 52 placebo controlled randomized 52 randomized Phase III 52 Azedra 52 Phase III clinical 52 Irinotecan 52 confirmatory Phase 3 51 glufosfamide 51 blind randomized placebo 51 TG# [001] 51 prospective randomized controlled 51 administered subcutaneously 51 placebo controlled 51 MAb 51 decitabine 51 tolerated dose MTD 51 safety tolerability pharmacokinetics 51 double blind placebo 51 Pivotal Trial 50 PRX# 50 multicenter clinical 50 Phase II 50 daclizumab 50 HuMax CD# 50 Allovectin 7 R 50 single ascending dose 50 SCH # 50 Initiates Phase 50 Phase IIa trial 50 multicenter 50 ELND# 50 multicentre 50 Phenoptin 50 cetrorelix 50 PXD# 50 IMC A# 49 dose escalation 49 randomized placebo controlled 49 eculizumab 49 TASQ 49 Synavive 49 CR# vcMMAE 49 humanized monoclonal antibody 49 HER2 positive metastatic breast 49 6R BH4 49 dose cohorts 49 ISIS # 49 relapsed refractory multiple myeloma 49 plus gemcitabine 49 randomized controlled clinical 49 active comparator 49 Phase III Trial 49 blinatumomab 49 randomized double 49 dose regimens 49 glatiramer acetate 49 dose escalation study 49 ZYBRESTAT 49 elagolix 49 Amigal 49 TargeGen